SB290157 has been commonly used as a C3aR antagonist in various disease models including Alzheimer’s Disease [88], intracerebral hemorrhage [25], and stroke [84], to elucidate C3aR-mediated pathways in inflammation and tissue injury. The gene discussed is C3AR1; the disease is early-onset autosomal dominant Alzheimer disease.